Annual Drug Patent Expirations for KORLYM
Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are thirteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for KORLYM.
This drug has twenty-eight patent family members in eleven countries.
The generic ingredient in KORLYM is mifepristone. Additional details are available on the mifepristone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
